As Health Economics and Outcomes Research (HEOR) and Real World Evidence (RWE) receive more attention within the life sciences, pharma in particular, global research organizations continue to develop strategies to navigate such complex study designs.
It is becoming apparent to many of these organizations that one of the best solutions is to leverage experienced service providers, who are also often knowledgeable about the policies Health Technology Assessment (HTA) bodies require across various regions. These challenges make the outsourcing of expert service providers inevitable and a key to driving the value story of products.
However, outsourcing can lead to long contracting times and difficulties in locating the right supplier, especially in growing markets such as HEOR & RWE. All of this leads one to ask: how does outsourcing support HEOR & RWE projects when the practice of outsourcing itself presents its own challenges?
Some questions that will be answered include:
- What is RWE and HEOR?
- What are some of the major challenges when sourcing HEOR and RWE?
- What sourcing trends are occurring in the global strategy and regulation of HEOR and RWE?
- What are the best practices and strategies when sourcing HEOR and RWE services?